Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment.
Trojano M, Avolio C, Ruggieri M, Defazio G, Giuliani F, Paolicelli D, Livrea P. Trojano M, et al. Among authors: Paolicelli D. Mult Scler. 1998 Jun;4(3):183-7. doi: 10.1177/135245859800400318. Mult Scler. 1998. PMID: 9762671 Clinical Trial.
The specificity of high serum sICAM-I levels (above M +/- 2 s.d. of control values) to assess the disease activity in MS resulted higher (100%) using clinical than Gd-MRI activity (76%) as gold standard. ...
The specificity of high serum sICAM-I levels (above M +/- 2 s.d. of control values) to assess the disease activity in MS resulted hig …
Age-related disability in multiple sclerosis.
Trojano M, Liguori M, Bosco Zimatore G, Bugarini R, Avolio C, Paolicelli D, Giuliani F, De Robertis F, Marrosu MG, Livrea P. Trojano M, et al. Among authors: Paolicelli D. Ann Neurol. 2002 Apr;51(4):475-80. doi: 10.1002/ana.10147. Ann Neurol. 2002. PMID: 11921053
Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.
Trojano M, Liguori M, Paolicelli D, Zimatore GB, De Robertis F, Avolio C, Giuliani F, Fuiani A, Livrea P; Southern Italy MS Group. Trojano M, et al. Among authors: Paolicelli D. Mult Scler. 2003 Oct;9(5):451-7. doi: 10.1191/1352458503ms948oa. Mult Scler. 2003. PMID: 14582768 Clinical Trial.
89 results
Jump to page
Feedback